IDH1 and glioblastoma: IDH1/2 mutation was highly associated with the prolonged overall survival (OS).17 Case 11, a 59 year-old woman, was diagnosed as anaplastic pleomorphic xanthoastrocytoma, WHO III, in September 2019, and recurred in March 2021 with histologically confirmed as GBM, WHO IV (Figure 6A).